Literature DB >> 328289

Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man.

W Dieterle, J W Faigle, C Montigel, M Sulc, W Theobald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 328289     DOI： 10.1007/bf00566534

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  20 in total

1.  [Metabolism of a derivative of 4-hydroxy-coumarin: 3(alfa-acetonyl-p-nitrobenzyl)4-hydroxy-coumarin (Sintrom) in man].

Authors:  C Blatrix; S Charonnat; J P Tillement; J Israel; J P Brevet; J Debraux; M Merlin
Journal:  Rev Fr Etud Clin Biol       Date:  1968-12

2.  Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.

Authors:  J P Tillement; R Zini; P d' Athis; G Vassent
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

3.  Absolute configurations of the four warfarin alcohols.

Authors:  K K Chan; R J Lewis; W F Trager
Journal:  J Med Chem       Date:  1972-12       Impact factor: 7.446

Review 4.  [Oral anticoagulants].

Authors:  E Renk; W G Stoll
Journal:  Fortschr Arzneimittelforsch       Date:  1968

5.  Effect of phenylbutazone on the binding of vitamin K antagonists to albumin.

Authors:  J P Tillement; R Zini; C Mattei; E Singlas
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

6.  Quantitative determination of dantrolene sodium and its metabolites by differential pulse polarography.

Authors:  P L Cox; J P Heotis; D Polin; G M Rose
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

7.  Mass spectral analysis in the identification of human metabolites of warfarin.

Authors:  W F Trager; R J Lewis; W A Garland
Journal:  J Med Chem       Date:  1970-11       Impact factor: 7.446

8.  Comparative metabolic study of nimetazepam and its desmethyl derivative (nitrazepam) in rats.

Authors:  Y Yanagi; F Haga; M Endo; S Kitagawa
Journal:  Xenobiotica       Date:  1975-04       Impact factor: 1.908

9.  Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man.

Authors:  W Dieterle; J W Faigle; H Mory; W J Richter; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

10.  Warfarin metabolism in man: identification of metabolites in urine.

Authors:  R J Lewis; W F Trager
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808
View more
  14 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Pharmacokinetic analysis of a new acenocoumarol tablet formulation during a bioequivalence study.

Authors:  J Popović; M Mikov; V Jakovljević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

3.  Anticoagulant activity of the enantiomers of acenocoumarol.

Authors:  T Meinertz; W Kasper; C Kahl; E Jähnchen
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

4.  Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?

Authors:  H H Thijssen; L G Baars
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

5.  Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers.

Authors:  W Couet; B Istin; J P Decourt; I Ingrand; J Girault; J B Fourtillan
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 6.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.

Authors:  Mike Ufer; Jan O Svensson; Kristopher W Krausz; Harry V Gelboin; Anders Rane; Gunnel Tybring
Journal:  Eur J Clin Pharmacol       Date:  2004-03-31       Impact factor: 2.953

8.  May mothers taking acenocoumarol breast feed their infants?

Authors:  M Houwert-de Jong; L J Gerards; C A Tetteroo-Tempelman; F A de Wolff
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Pharmacokinetics of the enantiomers of acenocoumarol in man.

Authors:  J Godbillon; J Richard; A Gerardin; T Meinertz; W Kasper; E Jähnchen
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

10.  The role of the intestinal microflora in the reductive metabolism of acenocoumarol in man.

Authors:  H H Thijssen; L G Baars; M J Hazen; A E Van den Bogaard
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.